NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 284 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $81,000 | -80.9% | 15,000 | -52.1% | 0.04% | -79.7% |
| Q4 2021 | $423,000 | -24.7% | 31,300 | 0.0% | 0.17% | -30.6% |
| Q3 2021 | $562,000 | +4.7% | 31,300 | 0.0% | 0.25% | +30.5% |
| Q2 2021 | $537,000 | -14.2% | 31,300 | 0.0% | 0.19% | -30.1% |
| Q1 2021 | $626,000 | +17.7% | 31,300 | 0.0% | 0.27% | +24.2% |
| Q4 2020 | $532,000 | +0.8% | 31,300 | -1.6% | 0.22% | -18.9% |
| Q3 2020 | $528,000 | -47.0% | 31,800 | -26.0% | 0.27% | -51.5% |
| Q2 2020 | $996,000 | +29.7% | 43,000 | 0.0% | 0.56% | +11.0% |
| Q1 2020 | $768,000 | -17.2% | 43,000 | 0.0% | 0.50% | -14.6% |
| Q4 2019 | $928,000 | – | 43,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |